Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)
The National Cancer Institute funds systematic evaluations of scientific evidence on carcinogenic hazards to humans to inform cancer research, control, and prevention; clinical trials are not allowed.
Browse similar grants
Funder: National Institutes of Health
Due Dates: January 9, 2027 (Submissions open) | February 9, 2027 (Application deadline, 5:00 p.m. local time)
Funding Amounts: $700,000 award floor and ceiling listed on Grants.gov; five-year project period; $800,000 planned for one award
Summary: Supports a Monographs Program that systematically evaluates and integrates scientific evidence on carcinogenic hazards to humans.
Key Information: Primary data collection, single-evidence-stream assessments, and clinical trials are not allowed.
Description
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), invites R01 applications to the Carcinogen Hazard Assessment Monographs Program (CHAMP). The recipient will lead evaluations of globally relevant carcinogenic hazards and serve as an authoritative reference for health agencies worldwide. Evaluations must integrate existing evidence from human cancer studies, experimental animal studies, and mechanistic research, as relevant to each agent.
“Agents” include chemicals, complex mixtures, physical agents, biological organisms, behaviors and lifestyle factors, environmental exposures, and occupations. The program supports rigorous, transparent, conflict-free expert evaluations, publication and global dissemination of monographs, and continuous quality improvement. Its goals are to identify cancer risks and preventable causes of cancer, guide research priorities, and inform cancer control and prevention.
